CFO
GMED icon

Callan Family Office’s Globus Medical GMED Stock Holding History

Callan Family Office’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$225K Buy
2,614
+111
+4% +$9.96K 0.01% 1031
2025
Q4 		$219K Buy
+2,503
New +$190K ﹤0.01% 1031

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Callan Family Office's GMED Position: Q1 2026 in Review

Callan Family Office increased its Globus Medical (GMED) stake by 4.4% in Q1 2026, buying an estimated $9.96K and bringing the position to 2,614 shares worth $225K. The position accounts for 0.01% of the portfolio, ranked #1031.

Callan Family Office first reported a position in GMED in Q4 2025 and has held it in 2 quarters since. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Callan Family Office held 2,614 shares of Globus Medical worth $225K as of Q1 2026.
  • Callan Family Office bought 111 Globus Medical shares in Q1 2026, an estimated $9.96K.
  • Globus Medical made up 0.01% of Callan Family Office's portfolio in Q1 2026, its #1031 holding.
  • Callan Family Office first reported a position in Globus Medical in Q4 2025 and has held it in 2 quarters since.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.